胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)

2018-12-27 中国医师协会胸外科医师分会 中国胸心血管外科临床杂志.2019,26(1):1-7.

胸壁肿瘤是胸外科领域常见的肿瘤类型,由于其涉及的组织器官和病理类型多样,包括骨、软组织、血液系统等多个系统,诊断和治疗方式也有所区别。对于大部分胸壁肿瘤而言,手术是其主要的治疗方式,术后造成的大范围胸壁缺损又需要进行胸壁重建。近年来,随着外科技术和植入器械的发展,胸壁肿瘤切除手术和胸壁重建手术也发生了巨大的变化。目前临床中可选择的重建材料和方法众多,但是尚缺乏高级别临床证据对各种胸壁重建技术和重建

中文标题:

胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)

发布日期:

2018-12-27

简要介绍:

胸壁肿瘤是胸外科领域常见的肿瘤类型,由于其涉及的组织器官和病理类型多样,包括骨、软组织、血液系统等多个系统,诊断和治疗方式也有所区别。对于大部分胸壁肿瘤而言,手术是其主要的治疗方式,术后造成的大范围胸壁缺损又需要进行胸壁重建。近年来,随着外科技术和植入器械的发展,胸壁肿瘤切除手术和胸壁重建手术也发生了巨大的变化。目前临床中可选择的重建材料和方法众多,但是尚缺乏高级别临床证据对各种胸壁重建技术和重建材料进行比较。胸壁重建的手术方式主要依据术者的经验和个人倾向进行选择,如何正确合理使用重建材料尚无明确规范。本共识基于此目的由部分中国胸外科专家共同制定。 

拓展指南:肿瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版))] GetToolGuiderByIdResponse(projectId=1, id=0a82a1c00168394b, title=胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版), enTitle=, guiderFrom=中国胸心血管外科临床杂志.2019,26(1):1-7., authorId=null, author=, summary=胸壁肿瘤是胸外科领域常见的肿瘤类型,由于其涉及的组织器官和病理类型多样,包括骨、软组织、血液系统等多个系统,诊断和治疗方式也有所区别。对于大部分胸壁肿瘤而言,手术是其主要的治疗方式,术后造成的大范围胸壁缺损又需要进行胸壁重建。近年来,随着外科技术和植入器械的发展,胸壁肿瘤切除手术和胸壁重建手术也发生了巨大的变化。目前临床中可选择的重建材料和方法众多,但是尚缺乏高级别临床证据对各种胸壁重建技术和重建, cover=, journalId=null, articlesId=null, associationId=320, associationName=中国医师协会胸外科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Dec 27 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>胸壁肿瘤是胸外科领域常见的肿瘤类型,由于其涉及的组织器官和病理类型多样,包括骨、软组织、血液系统等多个系统,诊断和治疗方式也有所区别。对于大部分胸壁肿瘤而言,手术是其主要的治疗方式,术后造成的大范围胸壁缺损又需要进行胸壁重建。近年来,随着外科技术和植入器械的发展,胸壁肿瘤切除手术和胸壁重建手术也发生了巨大的变化。目前临床中可选择的重建材料和方法众多,但是尚缺乏高级别临床证据对各种胸壁重建技术和重建材料进行比较。胸壁重建的手术方式主要依据术者的经验和个人倾向进行选择,如何正确合理使用重建材料尚无明确规范。本共识基于此目的由部分中国胸外科专家共同制定。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>肿瘤</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=5b6291c00168a243" title="影像学引导骨与软组织肿瘤冷冻消融治疗专家共识2018" target=_blank>影像学引导骨与软组织肿瘤冷冻消融治疗专家共识2018</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0a82a1c00168394b" title="胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)" target=_blank>胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=237bb1c0016e8189" title="中国消化道黏膜下肿瘤内镜诊治专家共识(2018版)" target=_blank>中国消化道黏膜下肿瘤内镜诊治专家共识(2018版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c99ca1c0016e7984" title="《中国临床肿瘤学会乳腺癌诊疗指南2018.V1》外科问题解读" target=_blank>《中国临床肿瘤学会乳腺癌诊疗指南2018.V1》外科问题解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0c62f1c0016e28d5" title="2018 AIMO/SIMIT意见书:积极治疗恶性肿瘤的丙肝病毒阳性患者的管理" target=_blank>2018 AIMO/SIMIT意见书:积极治疗恶性肿瘤的丙肝病毒阳性患者的管理</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%BF%E7%98%A4" target=_blank>有关肿瘤更多指南</a></ul>, tagList=[TagDto(tagId=85109, tagName=胸壁肿瘤切除), TagDto(tagId=85110, tagName=胸壁重建手术)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7166, appHits=124, showAppHits=0, pcHits=5717, showPcHits=1958, likes=269, shares=2, comments=20, approvalStatus=1, publishedTime=Sat Jan 05 00:04:17 CST 2019, publishedTimeString=2018-12-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 05 00:04:17 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 22:39:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版))])
胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)
下载请点击:
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=357457, encodeId=d7b435e4577d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:58 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357456, encodeId=ef5435e45628, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:53 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357455, encodeId=af4535e45599, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:50 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357454, encodeId=d1a635e4540a, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:46 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357453, encodeId=5f8c35e45337, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:42 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了长知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=357457, encodeId=d7b435e4577d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:58 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357456, encodeId=ef5435e45628, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:53 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357455, encodeId=af4535e45599, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:50 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357454, encodeId=d1a635e4540a, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:46 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357453, encodeId=5f8c35e45337, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:42 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=357457, encodeId=d7b435e4577d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:58 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357456, encodeId=ef5435e45628, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:53 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357455, encodeId=af4535e45599, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:50 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357454, encodeId=d1a635e4540a, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:46 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357453, encodeId=5f8c35e45337, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:42 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了长知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=357457, encodeId=d7b435e4577d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:58 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357456, encodeId=ef5435e45628, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:53 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357455, encodeId=af4535e45599, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:50 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357454, encodeId=d1a635e4540a, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:46 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357453, encodeId=5f8c35e45337, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:42 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=357457, encodeId=d7b435e4577d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:58 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357456, encodeId=ef5435e45628, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:53 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357455, encodeId=af4535e45599, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:50 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357454, encodeId=d1a635e4540a, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:46 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357453, encodeId=5f8c35e45337, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jan 07 10:12:42 CST 2019, time=2019-01-07, status=1, ipAttribution=)]
    2019-01-07 Y—xianghai

    学习了长知识

    0